AI assistant
Sending…
Cartesian Therapeutics, Inc. — Director's Dealing 2016
Dec 31, 2016
33483_dirs_2016-12-30_3d484cdb-e717-43c6-aaec-bc3a10fab36f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-12-28
Reporting Person: Kishimoto Takashi Kei (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-28 | Common Stock | M | 10000 | $2.77 | Acquired | 10000 | Direct |
| 2016-12-28 | Common Stock | S | 10000 | $17.55 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-12-28 | Employee Stock Option (right to buy) | $2.77 | M | 10000 | Disposed | 2021-09-07 | Common Stock (10000) | Direct |
Footnotes
F1: The shares underlying the option are fully vested.
More from Cartesian Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 9
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8